Skip to main content
Oxford University Press - PMC COVID-19 Collection logoLink to Oxford University Press - PMC COVID-19 Collection
. 2020 Dec 10:ciaa1804. doi: 10.1093/cid/ciaa1804

Comparison of Estimated SARS-CoV-2 Seroprevalence through Commercial Laboratory Residual Sera Testing and a Community Survey

Kristina L Bajema 1,, F Scott Dahlgren 1, Travis W Lim 1, Nicolette Bestul 1, Holly M Biggs 1, Jacqueline E Tate 1, Claudio Owusu 1, Christine M Szablewski 1,2, Cherie Drenzek 2, Jan Drobeniuc 1, Vera Semenova 1, Han Li 1, Peter Browning 1, Rita Desai 1, Monica Epperson 1, Lily T Jia 1, Natalie J Thornburg 1, Chris Edens 1, Alicia M Fry 1, Aron J Hall 1, Jarad Schiffer 1, Fiona P Havers 1
PMCID: PMC7799302  PMID: 33300579

Abstract

We compared severe acute respiratory syndrome–related coronavirus-2 seroprevalence estimated from commercial laboratory residual sera and a community household survey in metropolitan Atlanta during April-May 2020 and found these two estimates to be similar (4.94% versus 3.18%). Compared with more representative surveys, commercial sera can provide an approximate measure of seroprevalence.

Keywords: Severe acute respiratory syndrome–related coronavirus-2 (SARS-CoV-2), Seroprevalence, Coronavirus disease 2019 (COVID-19), Convenience sampling


Articles from Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America are provided here courtesy of Oxford University Press

RESOURCES